|
|
|
Volumn 10, Issue 3, 2000, Pages 162-170
|
|
How to manage metabolic complications of HIV therapy: What to do while we wait for answers
|
|
Author keywords
Anabolic steroids; Diet; Exercise; Fibric acid derivatives; Growth hormone; Lipodystrophy; Metabolic abnormalities; Metformin; Statins; Thiazolidinediones
|
|
Indexed keywords
ANABOLIC AGENT;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIDIABETIC AGENT;
ANTIRETROVIRUS AGENT;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
GROWTH HORMONE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STATIN;
ZIDOVUDINE;
CONFERENCE PAPER;
DIET;
EXERCISE;
HORMONAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIFESTYLE;
LIPODYSTROPHY;
METABOLIC DISORDER;
TREATMENT PLANNING;
ANABOLIC AGENTS;
ANTI-HIV AGENTS;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
EXERCISE THERAPY;
GEMFIBROZIL;
GROWTH HORMONE;
GUIDELINES;
HEPTANOIC ACIDS;
HIV INFECTIONS;
HUMANS;
HYPOGLYCEMIC AGENTS;
LIPODYSTROPHY;
METABOLIC DISEASES;
METFORMIN;
NUCLEOSIDES;
PROTEASE INHIBITORS;
PYRROLES;
REVERSE TRANSCRIPTASE INHIBITORS;
RISK FACTORS;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0034060845
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (41)
|
|
References (38)
|
